← Back to work
Works cited by this work
145 works
Work: Disrupting immune silence: Noncoding RNAs targeting the programmed cell death protein 1/programmed cell death ligand 1 axis in tumor immunity
Targeting non-coding RNAs to overcome cancer therapy resistance
Baoqing Chen, Mihnea P. Dragomir, Yang Chen +3
Review article20224 citationsABILIN28/ <i>let-7</i> /PD-L1 Pathway as a Target for Cancer Immunotherapy
Yanlian Chen, Chen Xie, Xiaohui Zheng +4
Article20193 citationsABICircRNAs: role in human diseases and potential use as biomarkers
Lorena Verduci, Emilio Tarcitano, Sabrina Strano +2
Review article20213 citationsABINon‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
Review article20233 citationsABIMechanisms of Tumor Cell–Intrinsic Immune Evasion
Stefani Spranger, Thomas F. Gajewski
Article20172 citationsABIImmunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment
Hany A. Omar, Ahmed T. El‐Serafi, Fatema Hersi +5
Review article20192 citationsABIMir-21 Suppression Promotes Mouse Hepatocarcinogenesis
Marta Correia de Sousa, Nicolas Calo, Cyril Sobolewski +12
Article20212 citationsABIThe role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
Wenxiao Jiang, Shuya Pan, Xin Chen +2
Review article20212 citationsABITurning cold tumors into hot tumors by improving T-cell infiltration
Review article20212 citationsABImiR-19 regulates the expression of interferon-induced genes and MHC class I genes in human cancer cells
Jing Li, Taoyan Lin, Lin Chen +13
Article20202 citationsABIThe role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications
Yu Ma, Ting Wang, Xudong Zhang +2
Review article20242 citationsABINoncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application
Le Zhang, Xiaonan Xu, Xiulan Su
Review article20202 citationsABI